Diaryl ethers as opioid receptor antagonist

A compound of the formula (I) wherein the variables X 1 to X 10 , R 1 to R 7 including R 3' , E, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DE LA TORRE MARTA GARCIA, HOLLOWAY WILLIAM GLEN, CHAPPELL MARK DONALD, STUCKY RUSSELL DEAN, WOLFE CHAD NOLAN, MITCH CHARLES HOWARD, QUIMBY STEVEN JAMES, TAKEUCHI KUMIKO, SIEGEL MILES GOODMAN, FRITZ JAMES ERWIN, DIAZ BUEZO NURIA, SMITH DANA RAE, MATT JAMES EDWARD JUNIOR, BLANCO-PILLADO MARIA-JESUS, PEDREGAL-TERCERO CONCEPCION, THOMAS ELIZABETH MARIE
Format:	Patent
Sprache:	eng ; slv
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A compound of the formula (I) wherein the variables X 1 to X 10 , R 1 to R 7 including R 3' , E, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed.